U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Nancy Ham sold 1,172 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the transaction, the director now owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
U.S. Physical Therapy Stock Performance
USPH stock traded down $2.44 during midday trading on Tuesday, hitting $92.17. The stock had a trading volume of 111,576 shares, compared to its average volume of 91,789. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of 98.05, a P/E/G ratio of 4.40 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The stock has a 50-day simple moving average of $83.80 and a 200 day simple moving average of $91.31. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. During the same period in the previous year, the business posted $0.76 earnings per share. The firm’s revenue was up 10.4% compared to the same quarter last year. As a group, equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.
U.S. Physical Therapy Announces Dividend
Wall Street Analyst Weigh In
A number of analysts have commented on USPH shares. Bank of America reaffirmed a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, Barrington Research reaffirmed an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 7th.
Get Our Latest Research Report on U.S. Physical Therapy
Institutional Investors Weigh In On U.S. Physical Therapy
Several institutional investors have recently bought and sold shares of the company. Silvercrest Asset Management Group LLC acquired a new stake in shares of U.S. Physical Therapy during the 1st quarter worth $8,158,000. Harbor Capital Advisors Inc. grew its holdings in shares of U.S. Physical Therapy by 292.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company’s stock worth $701,000 after purchasing an additional 5,652 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of U.S. Physical Therapy by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock worth $121,065,000 after purchasing an additional 10,175 shares in the last quarter. CANADA LIFE ASSURANCE Co grew its holdings in shares of U.S. Physical Therapy by 5.8% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company’s stock worth $1,423,000 after purchasing an additional 696 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its holdings in shares of U.S. Physical Therapy by 18.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after purchasing an additional 186 shares in the last quarter.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading
- Five stocks we like better than U.S. Physical Therapy
- 10 Best Airline Stocks to Buy
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Transportation Stocks Investing
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.